Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks
|
|
- Virginia Blankenship
- 5 years ago
- Views:
Transcription
1 Blackwell Science, LtdOxford, UKCHACephalalgia Blackwell Publishing, Original ArticleAnti-nociceptive mechanisms of migraine drugs Z Katsarava et al. doi: /j x Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks Z Katsarava, V Limmroth, O Baykal, D Akguen, H-C Diener & H Kaube Institute of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK Katsarava Z, Limmroth V, Baykal O, Akguen D, Diener H-C & Kaube H. Differences of anti-nociceptive mechanisms of migraine drugs on the trigeminal pain processing during and outside acute migraine attacks. Cephalalgia 04; 24: London. ISSN The aim of this study was to investigate central anti-nociceptive mechanisms of i.v. acetylsalicylic acid (ASA) and oral zolmitriptan (ZOL) in migraine patients and healthy subjects using the nociceptive blink reflex (nbr). Twenty-eight migraine patients received ASA (n = 14, 0 mg i.v) or ZOL (n = 14, 5 mg p.o) during the acute migraine attack and interictally. Thirty healthy subjects received either ASA or ZOL vs. placebo using a double blind cross over design. nbr was recorded in all patients and subjects before, and 90 min after treatment. ASA and ZOL did not inhibit nbr responses in healthy subjects. Both ASA and ZOL suppressed nbr responses (ASA by 68%, ZOL by 78%) only during the acute attack but not interictally. The data suggest, that the anti-nociceptive effects of migraine drugs on the trigeminal nociceptive processing are different during and outside an acute migraine attack. Migraine, trigeminal nociception, blink reflex Dr. Zaza Katsarava Department of Neurology Hufelandstr Essen Tel , fax , zaza.katsarava@uni-essen.de Received 29 July 03, accepted 27 November 03 Introduction Migraine is a common but nevertheless complex neurobiological disorder characterized by attacks of unilateral stabbing, pulsating headache (1). Migraine head pain arises within the trigeminal system (2). The pathophysiology of migraine headache as well the anti-nociceptive mechanisms of migraine drugs are still poorly understood. We previously reported a novel technique for studying central trigeminal pain processing using the nociceptive blink reflex (nbr) (3, 4). The nbr was elicited using a novel stimulating electrode, which by virtue of its concentric geometry produces high current densities by low current intensities. Thus, depolarization is limited to the superficial layer of the dermis containing nociceptive A-delta fibres but does not reach the deeper, A-beta fibre containing, layers. The nbr has been shown to be highly sensitive to changes in trigeminal nociception (5). Using the nbr a temporary facilitation of the trigeminal nociceptive system could be detected during acute migraine attacks but not interictally (6). The facilitation of the trigeminal nociceptive system has not been found during peripheral pain such as frontal sinusitis (7). Furthermore, nbr responses were suppressed following treatment with acetylsalicylic acid (ASA) and Zolmitriptan (ZOL) during the migraine attack in parallel to the headache relief (6). Therefore, the nbr has been thought to be a sensitive marker for the functional state of the trigeminal nociceptive system. The aim of the current study was to evaluate whether nbr recordings can be used to assess central anti-nociceptive effects of potential migraine substances in humans. Therefore effects of two potent migraine drugs such as ASA and ZOL on the nbr were studied in migraine patients during and outside the acute attack and in healthy subjects. The data of the first 17 patients has been published previously (6). 657
2 658 Z Katsarava et al. Methods The study was approved by the local ethics committee. Informed content was obtained from all subjects and patients prior the investigation. Study design Twenty-eight patients with migraine without aura (1) (21 women, 7 men; mean age 27 ± 5.5 years) were studied. Mean attack frequency was 2.8 ± 1.3 per month. Mean duration of suffering from migraine was 11.1 ± 5.4 years. None of the patients received preventive medication for the last 3 months. Thirty age and gender matched healthy subjects (19 women, 11 men) with a mean age of 25.7 ± 4.8 years were investigated. Fourteen patients received acetylsalicylic acid (ASA, lysine acetylsalicylate iv, Aspisol 0 mg, Bayer-Leverkusen, Leverkusen, Germany) during a strictly unilateral migraine attack within the first six hours after onset. All patients received ASA again during the interictal period. It was defined as migraine free at least 3 days before and after investigation. Fourteen patients received zolmitriptan (ZOL, Zomig 5 mg po, AstraZeneca, Plankstadt, Germany) during a strictly unilateral migraine attack within six hours after onset and interictally. Headache intensity was measured using the visual analogue scale (0 = no headache, 10 = very severe headache) before and 90 min after drug treatment. nbr recordings were performed in all patients before as well as and 90 min after drug treatment. Thirty healthy subjects were investigated. None of them had a personal or family history of migraine or cluster headache (1). Fifteen subjects received ASA or placebo using a double blind cross over study design. Fifteen subjects received ZOL or placebo using a similar double blind cross over design. nbr recordings were performed in all subjects before as well as and 90 min after drug treatment. Electrophysiological stimulation and recording setup nbr were elicited using a concentric surface stimulating electrode, as described previously (4). Individual pain and tactile perception thresholds were detected using ascending and descending single pulses in 0.2 ma steps. Stimulation parameters Stimulation. Blocks of 6 stimuli (monopolar square wave pulses, DS7A, Digitimer, UK), Stimulation intensity was 1.5 times the individual pain threshold, which was determined in subjects and patients during the first visit. Migraine patients were invited for the first evaluation outside the acute migraine attack. The stimulation intensity was kept constant for each subject or patient during the entire study. Median stimulation intensity in migraine patients was 1.4 ma range ; median stimulation intensity in the group of healthy subjects was 1.35 ma, range Stimulus duration was 0.3 ms, interstimulus interval s (pseudo-randomized). Recording. Bilateral surface recording electrodes (silver chloride) placed infra-orbitally and at the root of the nose, bandwidth 1Hz-1 khz; sampling rate 2.5 khz, sweep length 150 ms (11 micro, Signal Averager, Cambridge Electronic Design, Cambridge, UK). Analysis. Curves were analysed by an investigator blinded to the experimental conditions. The first recording sweep was discarded to avoid contamination by initial startle responses. Onset latencies of R2 responses were measured in individual sweeps. A mean value for each block was calculated. For analysis of the area under the curve (AUC) of the R2 response five subsequent curves were rectified, demeaned and averaged. The AUC of the R2 response was calculated between 27 and 87 ms using PC-based offline analysis with custom written software as described previously (4); Matlab, 5.3 MathWorks, Natick, Massachusetts (US). Data analysis. Differences in mean onset latencies for baseline and after treatment were compared. Because of heterogeneity of the raw AUCs, data were normalized and analysed as percentage deviations from the baseline values (baseline values considered as %). Statistical analysis Migraine patients ANOVA for repeated measurements was used to compare VAS scores of migraine patients during acute attacks before and 90 min after drug treatment. Between subject factor: DRUG (ASA vs. ZOL); within subject factor: TIME (baseline vs. 90 min after drug treatment).
3 Anti-nociceptive mechanisms of migraine drugs 659 Two ANOVAs for repeated measurements were used to compare onset latencies and AUCs in migraine patients during acute attacks and interictally. Between subject factor: DRUG (ASA vs. ZOL); within subject factors: ATTACK (acute attack vs. interictally); TIME (baseline min 90 min after treatment). Healthy subjects Two ANOVAs for repeated measurements were used to compare onset latencies and AUC before and after treatment with ASA. Between subject factor: DRUG (drug: ASA or ZOL vs. placebo); within subject factors TIME (baseline min 90 min after treatment). Two ANOVAs for repeated measurements were used to compare onset latencies and AUC before and after treatment with ZOL. Between subject factor: DRUG (drug: ASA or ZOL vs. placebo); within subject factors TIME (baseline min 90 min after treatment). Student s t-tests with Bonferoni s correction for multiple comparisons were used for posthoc analysis of significant factors and their interactions and group means. Factors and interactions with error probabilities P < 0.05 were considered significant. Results Clinical results All patients suffered from strictly unilateral moderate to severe migraine headache (mean VAS score: 6.9 ± 1.2). All patients reported a significant reduction of the headache intensity by ASA (VAS baseline = 6.7 ± 1.1 vs. VAS 90 min after treatment = 0.9 ± 1.2) or ZOL (VAS baseline = 7.0 ± 1.4 vs. VAS 90 min after treatment = 1.0 ± 1.4; TIME d.f. = 1, F = 576.4, P < ). No significant differences were observed between the two drug effects (DRUG d.f. = 1, F = 0.067, P = 0.79). Electrophysiological results Migraine patients A significant increase of nbr onset latencies (TIME*ATTACK d.f. = 2, F = 8.6, P < 0.001) and a significant suppression of AUCs (TIME*ATTACK d.f. = 2, F = 26.8, P < 0.001) were observed after application of ASA and ZOL during acute migraine attack but not interictally (Fig. 1a,b). No significant differences were found comparing the effects of ASA and ZOL (Tables 1 and 2). (a) (b) AUC (%) 0 0 BL min 90 min BL min 90 min (c) (d) 0 BL min 90 min BL min 90 min Figure 1 Effects of acetylsalicylic acid (ASA) and zolmitriptan (ZOL) on areas under the curves of the nociceptive blink reflex. Data are shown as mean values and standard errors of the mean. (a) ASA in migraine patients during the acute attack ( ) and interictally ( ). (b) ZOL in migraine patients during the acute attack ( ) and interictally ( ). (c) ASA ( ) vs. placebo in healthy subjects ( ). (d) ZOL ( ) vs. placebo in healthy subjects ( ). BL = baseline, min, 90min after treatment.
4 6 Z Katsarava et al. Table 1 Effects of acetylsalicylic acid and zolmitriptan on onset latencies and areas under the curves (AUC) in migraine patients during the acute attack and interictally Migraine Interictally Baseline min 90 min Baseline min 90 min Acetyl salicylic acid Onset latencies (ms) 42.3 ± 2.8* 45.8 ± ± ± ± ± 5.6 AUC (%) 58.7 ± ± 12.7* 85.1 ± ± 31.4 Zolmitriptan Onset latencies (ms) 41.7 ± 3.5* 46.0 ± ± ± ± ± 4.2 AUC (%) 32.6 ± ± 14.3* 79.6 ± ± 24.4 *P < Table 2 Effects of acetylsalicylic acid and zolmitriptan vs. placebo on onset latencies and areas under the curves (AUC) in healthy subjects Drug (ASA or ZOL) Placebo Baseline min 90 min Baseline min 90 min Acetylsalicylic acid Onset latencies (ms) 50.0 ± ± ± ± ± ± 7.4 AUC (%).4 ± ± ± ± 34.5 Zolmitriptan Onset latencies (ms) 49.7 ± ± ± ± ± ± 5.5 AUC (%) 98.6 ± ± ± ± 32.9 Healthy subjects No differences were found between the ASA and placebo with regard to onset latencies (TIME*DRUG d.f. = 2, F = 0.099, P = 0.91) or AUCs (TIME*DRUG d.f. = 2, F = 1.3, P = 0.28; Fig. 1c). No differences were found between the ZOL and placebo with regard to onset latencies (TIME*DRUG d.f. = 2, F = 0.45, P = 0.64) or AUCs (TIME*DRUG d.f. = 2, F = 0.46, P = 0.63; Fig. 1d). Discussion There are two important findings in this study Firstly, a strong inhibitory effect of acetylsalicylic acid and zolmitriptan on trigeminal nociceptive transmission was observed during but not outside the acute migraine attack. Secondly, no differences were found between placebo and acetylsalicylic acid or zolmitriptan in healthy subjects. We previously showed, that nbr can be used as a sensitive marker for the functional state of the trigeminal nociceptive system. nbr responses were facilitated during the acute migraine attack and normal between attacks (7, 6, 7). In parallel to headache relief, nbr responses were strongly suppressed by acetylsalicylic acid and zolmitriptan during acute migraine attack (6). Here, in a larger number of patients the same effect was seen. Interestingly, these anti-nociceptive effects have not been found in the same patients after administration of acetylsalicylic acid and zolmitriptan interictally. This difference indicates that within the trigeminal system the central anti-nociceptive effects of acetylsalicylic acid and zolmitriptan differ during and outside an acute migraine attack. The acute migraine attack is characterized by dysfunction of nociceptive and nonnociceptive brain structures at cortical (8, 9), diencephalic (10) and brain stem levels (11, 12). As the most likely substrate for migraine head pain the trigeminal nociceptive system is significantly involved into this global brain dysfunction (6). The fact, that nbr responses were suppressed only during acute migraine attack, but not interictally might reflect a modulatory effect of migraine drugs on the trigeminal nociceptive system. It is possible, that migraine drugs such as zolmitriptan and acetylsalicylic acid strongly suppress the facilitated trigeminal nociception but do not or only to some extent affect the trigeminal nociceptive system in the resting state. The trigeminal reflexes,
5 Anti-nociceptive mechanisms of migraine drugs 661 however, are strongly influenced by supra-segmental control at cortical level and by cognitive factors (13, 14). Therefore, these higher cortical mechanisms, such as arousal or expectation of pain relief may partly account for the observed suppression of nbr responses. Another explanation for different effects of migraine drugs during and outside the acute migraine attack could be an impaired function of the blood brain barrier controlling access of migraine drugs to the brain stem as suggested by clinical (15) and experimental animal data (16). In experimental animals intravenous zolmitriptan and acetylsalicylic acid, both, have been shown to be able to cross the blood brain barrier and affect central pain processing (17, 18). A direct inhibitory effect of zolmitriptan on second-order trigeminal neurons has been shown after microiontophoretic administration (19). In migraine patients and healthy subjects zolmitriptan modulated the intensity dependence of cortical auditory evoked potentials suggesting a change in serotonergic sensory control (). Similarly, antinociceptive effects of acetylsalicylic acid have been demonstrated in animals (21). Thus, although acetylsalicylic acid and zolmitriptan, both penetrate blood brain barrier easily, it is possible, that an impaired blood brain barrier during migraine attack could increase their central anti-nociceptive effects. In healthy subjects we could not find any differences between zolmitriptan or acetylsalicylic acid and placebo. This finding could be explained by an insufficient sensitivity of the nbr method. In a recent study using a similar stimulation and recording paradigm a significant inhibition of the contralateral nbr responses by a novel adenosine A1 receptor agonist GR79236 was seen. On the ipsilateral side the suppression did not reach statistical significance (22). Whether the contralateral nbr responses are more sensitive to pharmacological intervention than ipsilateral responses is not known. Another tentative explanation is that GR79236 is a more potent inhibitor of central trigeminal transmission than acetylsalicylic acid or zolmitriptan as observed in similar animal assays (23). Whether this is of relevance for the clinical efficacy in migraine remains to be addressed in clinical trials. The lack of a detectable effect of acetylsalicylic acid and zolmitriptan on nbr in healthy volunteers suggests that this reflex response cannot be used as a pharmacological screening tool in the search for drugs with anti-migraine action in healthy subjects. Several attempts have been made to use protective reflexes and their laboratory surrogates as human models in physiology and pharmacology. The corneal reflex has been suggested to be nociceptive since the human cornea is predominantly innervated by nociceptive A-delta (24). In healthy subjects using the corneal reflex anti-nociceptive effects of several drugs including acetylsalicylic acid and piroxocam were demonstrated (25, 26). Both studies, however, had a relatively low sample sizes and were not placebo controlled. The main draw back of the study is the lacking of placebo control in migraine patients treated with acetylsalicylic acid or zolmitriptan. It could be argued that the presence of the placebo control would reduce the net size of the drug effect. However, we found a very strong anti-nociceptive effect (reduction of R2 AUCs by 70 %) of ASA and ZOL in migraine patient during acute attack. Interictally this effect was significantly lower, approximately 25%. A similar reduction was found also in healthy subjects either by ASA and ZOL or by placebo. This reduction is most likely caused by the unspecific habituation process as shown previously by Katsarava et al. (3). Therefore, although it is not known to which extent the placebo effect may be larger during acute migraine it is unlikely that it could account for the whole extent of the observed reduction. Hence, the main finding of this study is that both potent migraine drugs, acetylsalicylic acid and zolmitriptan suppressed trigeminal nociceptive processing during acute migraine attacks but not interictally and not in healthy subjects. And finally, the data suggest, that the nbr technique is an useful tool to quantify the activation of the trigeminal nociceptive system during the acute migraine attack and to evaluate the central anti-nociceptive effects of migraine drugs during the state of facilitation. Acknowledgements The study was supported by a research grant of the Bayer AG, Leverkusen, Germany. References 1 Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd edn. Cephalalgia 04; 24 Suppl 1: Goadsby PB, Lipton RB, Ferrai MD. Migraine. current understanding and management. N Engl J Med 02; 346: Katsarava Z, Ellrich J, Diener HC, Kaube H. Optimized stimulation and recording parameters of human nociception specific blink reflex recordings. Clin Neurophysiol 02; 113: Kaube H, Katsarava Z, Kaufer T, Diener HC, Ellrich J. A new method to increase nociception specifity of the human blink reflex. Clin Neurophysiol 00; 111:413 6.
6 662 Z Katsarava et al. 5 Katsarava Z, Frings M, Kaube H, Diener HC, Limmroth V. Selective damage of trigeminal Adelta fibres in Raeder s syndrome following dissection of the ICA detected by a nociceptive blink reflex. Cephalalgia 02; 22: Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J, Diener HC. Acute migraine headache: Possible sensitization of neurons in the spinal trigeminal nucleus? Neurology 02; 58: Katsarava Z, Lehnerdt G, Duda B, Ellrich J, Diener HC, Kaube H. Sensitization of trigeminal nociception specific for migraine but not pain of sinusitis. Neurology 02; 59: de Tommaso M, Guido M, Libro G, Losito L, Sciruicchio V, Monetti C, et al. Abnormal brain processing of cutaneous pain in migraine patients during the attack. Neurosci Lett 02; 333: Evers S, Quibeldey F, Grotemeyer KH, Suhr B, Husstedt IW. Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 1999; 19: Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tuedskov JF, Olesen J, et al. Premonitory symptoms in migraine: An electronic diary study. Neurology 03; : Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. The Lancet 01; 357: Weiller C, May A, Limmroth V, Jüptner M, Kaube H, van Schayck R, et al. Brain stem activation in spontaneous human migraine attacks. Nature Med 1995; 1: de Tommaso M, Murasecco D, Libro G, Guido M, Sciruicchio V, Specchio LM, et al. Modulation of trigeminal reflex excitability in migraine: effects of attention and habituation on the blink reflex. Int J Psychophysiol 02; 44: Rossi B, Vista M, Farnetani W, Gabrielli L, Vignocchi G, Bianchi F, et al. Modulation of electrically elicited blink reflex components by visual and acoustic prestimuli in man. Int J Psychophysiol 1995; : Bates D, Ashford E, Dawson R, Ensink FM, Gilhus NE, Olesen J, et al. Subcutaneous sumatriptan during the migraine aura. Neurology 1994; 44: Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurones only after blood brain barrier disruption. Br J Pharmacol 1993; 109: Goadsby PJ, Knight YE. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia 1997; 17: Kaube H, Hoskin KL, Goadsby PJ. Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache 1993; 33: Storer RJ, Goadsby PJ. Microiontophoretic application of serotonin (5HT) 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain 1997; : Proietti-Cecchini A, Afra J, Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central effect for the 5HT1B/1D agonist zolmitriptan (311C9, Zomig (R). Cephalalgia 1997; 17: Ellrich J, Schepelmann K, Pawlak M, Messlinger K. Acetylsalicylic acid inhibits meningeal nociception in rat. Pain 1999; 81: Giffin NJ, Kowacs F, Libri V, Williams P, Goadsby PJ, Kaube H. Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia 03; 23: Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE. Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain 02; 125: Cruccu G, Ferracuti S, Leardi MG, Fabbri A, Manfredi M. Nociceptive quality of the orbicularis oculi reflexes as evaluated by distinct opiate- and benzodiazepine-induced changes in man. Brain Res 1991; 556: Fabbri A, Cruccu G, Sperti P, Ridolfi M, Ciampani T, Leardi MG, et al. Piroxicam-induced analgesia: evidence for a central component which is not opioid mediated. Experientia 1992; 48: Ferracuti S, Leardi MG, Cruccu G, Fabbri A, Itil TM. Analgesic-antiinflammatory drugs inhibit orbicularis oculi reflexes in humans via a central mode of action. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:
Painful stimulation of the temple during optokinetic stimulation triggers migraine-like attacks in migraine sufferers
Blackwell Science, LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 2004253219224Original ArticleMotion sickness and migrainea Granston & PD Drummond doi:10.1111/j.1468-2982.2004.00844.x Painful
More informationPrednisone vs. placebo in withdrawal therapy following medication overuse headache
doi:10.1111/j.1468-2982.2007.01488.x Prednisone vs. placebo in withdrawal therapy following medication overuse headache L Pageler 1,2, Z Katsarava 2, HC Diener 2 & V Limmroth 1,2 1 Department of Neurology,
More informationLateralized nociceptive blink reflex habituation deficit in episodic cluster headache: Correlations with clinical features
Original Article Lateralized nociceptive blink reflex habituation deficit in episodic cluster headache: Correlations with clinical features Cephalalgia 2015, Vol. 35(7) 600 607! International Headache
More informationEarly treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan
Blackwell Science, LtdOxford, UKCHACephalalgia1468-2982Blackwell Science, 20042411925933Original ArticleEarly treatment of migraine with sumatriptanj Scholpp et al. Early treatment of a migraine attack
More informationHEADACHE PATHOPHYSIOLOGY
HEADACHE PATHOPHYSIOLOGY Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies Director, Headache Research and Treatment
More informationEvidence of persistent central sensitization in chronic headaches: a multi-method study
J Headache Pain (2008) 9:295 300 DOI 10.1007/s10194-008-0061-7 ORIGINAL Evidence of persistent central sensitization in chronic headaches: a multi-method study Elena Filatova Æ Nina Latysheva Æ Alexey
More informationPosterior Cerebral Hypoperfusion in Migraine without Aura Marie Denuelle, MD Neurology Service, Rangueil Hospital Toulouse, France
Posterior Cerebral Hypoperfusion in Migraine without Aura Marie Denuelle, MD Neurology Service, Rangueil Hospital Toulouse, France Most of the cerebral blood flow (CBF) studies in migraine have introduced
More informationThe prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients
Blackwell Publishing LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 20062006261012091213Original ArticleThe prevalence of premonitory symptoms in migrainegg Schoonman et al. The prevalence of premonitory
More informationACUTE TREATMENT FOR MIGRAINE. Cristina Tassorelli
The European Headache School 2012 ACUTE TREATMENT FOR MIGRAINE Cristina Tassorelli Headache Science Centre, IRCCS Neurological Institute C. Mondino Foundation - Pavia University Centre for Adaptive Disorders
More informationA New Era of Migraine Management: The Challenging Landscape in Prevention
Provided by MediCom Worldwide, Inc. Supported by an educational grant from Teva Pharmaceuticals What is a Neuropeptide? Small chains of amino acids released by neural cells (neurons or glial cells) to
More informationPharmacology of reflex blinks in the rat: a novel model for headache research
Jones et al. The Journal of Headache and Pain (2016) 17:96 DOI 10.1186/s10194-016-0686-x The Journal of Headache and Pain METHODOLOGY Pharmacology of reflex blinks in the rat: a novel model for headache
More informationMigraine and hormonal contraceptives
Migraine and hormonal contraceptives Department of Community Medicine, Systems Epidemiology University of Tromsø, November 2017 Nora Stensland Bugge Medical research student Presentation outline What is
More informationFaculty Disclosures. Learning Objectives
WWW.AMERICANHEADACHESOCIETY.ORG Pathophysiology Content developed by: Andrew C. Charles, MD, FAHS, Peter J. Goadsby, MD, PhD, FAHS Donna Gutterman, PharmD Faculty Disclosures ANDREW C. CHARLES, MD, FAHS
More informationANTIMIGRAINE MEDICINES
1 07.00.00.00 - ANTIMIGRAINE MEDICINES 1. Summary statement For acute migraine therapy the following new medicine is proposed: Sumatriptan 50 mg. 2. 3. Global Campaign to Reduce the Burden of Headache
More informationThe use of combination therapies in the acute management of migraine
REVIEW The use of combination therapies in the acute management of migraine Abouch Valenty Krymchantowski Headache Center of Rio, Rio de Janeiro, Brazil; Outpatient Headache Unit of the Instituto de Neurologia
More informationPain Pathways. Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH
Pain Pathways Dr Sameer Gupta Consultant in Anaesthesia and Pain Management, NGH Objective To give you a simplistic and basic concepts of pain pathways to help understand the complex issue of pain Pain
More informationComparison of dynamic (brush) and static (pressure) mechanical allodynia in migraine
Thomas Jefferson University Jefferson Digital Commons Department of Neurology Faculty Papers Department of Neurology July 2006 Comparison of dynamic (brush) and static (pressure) mechanical allodynia in
More informationNeurophysiology of migraine
J Headache Pain (2001) 2:S67 S71 Springer-Verlag 2001 MIGRAINE AND PATHOPHYSIOLOGY Giorgio Sandrini Alberto Proietti Cecchini Sonya Ivanova Hristova Grazia Sances Giuseppe Nappi Neurophysiology of migraine
More informationA new questionnaire for assessment of adverse events associated with triptans: methods of assessment influence the results. Preliminary results
J Headache Pain (2004) 5:S112 S116 DOI 10.1007/s10194-004-0123-4 Michele Feleppa Fred D. Sheftell Luciana Ciannella Amedeo D Alessio Giancarlo Apice Nino N. Capobianco Donato M.T. Saracino Walter Di Iorio
More informationDavid W. Dodick M.D. Professor Director of Headache Medicine Department of Neurology Mayo Clinic Phoenix Arizona USA
Headache Masters School 2013 in Asia Sunday March 24, 2013 Procedural Medicine Workshop Onabotulinumtoxin A: Evidence, Injection Technique, and Mechanism of Action David W. Dodick M.D. Professor Director
More informationTreatment of Intractable Hemicrania Continua by Occipital Nerve Stimulation
Treatment of Intractable Hemicrania Continua by Occipital Nerve Stimulation 1 Sarah Miller MBBS, MRCP 2 Laurence Watkins FRCS, PhD and 1 Manjit Matharu FRCP, PhD 1 Headache Group, Institute of Neurology
More informationOn the Pathophysiology of Migraine Links for Empirically Based Treatment With Neurofeedback
Applied Psychophysiology and Biofeedback, Vol. 27, No. 3, September 2002 ( C 2002) On the Pathophysiology of Migraine Links for Empirically Based Treatment With Neurofeedback Peter Kropp, 1,2 Michael Siniatchkin,
More informationNitroglycerin provocation in normal subjects is not a useful human migraine model?
Original Article Nitroglycerin provocation in normal subjects is not a useful human migraine model? Cephalalgia 30(8) 928 932! International Headache Society 2010 Reprints and permissions: sagepub.co.uk/journalspermissions.nav
More informationSeizure: the clinical manifestation of an abnormal and excessive excitation and synchronization of a population of cortical
Are There Sharing Mechanisms of Epilepsy, Migraine and Neuropathic Pain? Chin-Wei Huang, MD, PhD Department of Neurology, NCKUH Basic mechanisms underlying seizures and epilepsy Seizure: the clinical manifestation
More informationAuditory Brainstem Evoked Responses In Migraine Patients
ISPUB.COM The Internet Journal of Neurology Volume 12 Number 1 Auditory Brainstem Evoked Responses In Migraine Patients D Kaushal, S Sanjay Munjal, M Modi, N Panda Citation D Kaushal, S Sanjay Munjal,
More informationEmbriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second
Embriologically, The head is formed from the first two cervical segments (except the mandible, which is formed by the third). The first and second cervical vertebra are also derived from these two segments.
More informationZolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose response study
is effective and well tolerated in Japanese patients with migraine: a dose response study F Sakai 1, M Iwata 2, K Tashiro 3, Y Itoyama 4, S Tsuji 5, Y Fukuuchi 6, G Sobue 7, K Nakashima 8 & M Morimatsu
More informationReview of frovatriptan in the treatment of migraine
EXPERT OPINION Review of frovatriptan in the treatment of migraine Leslie Kelman Headache Center of Atlanta, Atlanta, GA, USA Abstract: Triptans are recommended for the acute treatment of moderate to severe
More informationSupraorbital nerve stimulation Cefaly Device - FDA Approved for migraine prevention (also being investigated as acute therapy)
NEUROSTIMULATION/NEUROMODULATION UPDATE Meyer and Renee Luskin Andrew Charles, M.D. Professor Luskin Chair in Migraine and Headache Studies Director, UCLA Goldberg Migraine Program David Geffen School
More informationValue of postmarketing surveillance studies in achieving a complete picture of antimigraine agents: using almotriptan as an example
J Headache Pain (2006) 7:27 33 DOI 10.1007/s10194-006-0266-6 ORIGINAL Julio Pascual Hans-Christoph Diener Hélène Massiou Value of postmarketing surveillance studies in achieving a complete picture of antimigraine
More informationSYLLABUS SPRING 2011 COURSE: NSC NEUROBIOLOGY OF PAIN
SYLLABUS NSC 4358 NEUROBIOLOGY OF PAIN SPRING 2011 1 SYLLABUS SPRING 2011 COURSE: NSC 4358 001 NEUROBIOLOGY OF PAIN Instructor: Aage R. Møller PhD E-mail: AMOLLER@UTDALLAS.EDU Class schedule: Main Campus:
More informationGreg Book. September 25, 2007 Olin Neuropsychiatry Research Center
Migraine Pathogenesis Greg Book September 25, 2007 Olin Neuropsychiatry Research Center Migraine Migraine i affects approximately 19.2% of females and 6.6% of males in the United States. (Patel, Bigal
More informationmedications. This was an openlabel study consisting of patients with migraines who historically failed to respond to oral triptan
J Headache Pain (2007) 8:13 18 DOI 10.1007/s10194-007-0354-7 ORIGINAL Seymour Diamond Fred G. Freitag Alexander Feoktistov George Nissan Sumatriptan 6 mg subcutaneous as an effective migraine treatment
More informationStimulation Ranges, Usage Ranges, and. Paresthesia Mapping During Occipital Nerve Stimulation. Introduction ORIGINAL ARTICLE ABSTRACT
NEUROMODULATION: TECHNOLOGY AT THE NEURAL INTERFACE Volume 11 Number 1 2008 http://www.blackwell-synergy.com/loi/ner ORIGINAL ARTICLE Stimulation Ranges, Usage Ranges, and Blackwell Publishing Inc Paresthesia
More informationInhibition by sumatriptan of central trigeminal neurones only
Br. J. Pharmacol. (I 993), 19, 788 792 Br. J. Pharmacol. (1993), 19, 788-792 'PI Macmillan Press Ltd, 1993 Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption
More information211MDS Pain theories
211MDS Pain theories Definition In 1986, the International Association for the Study of Pain (IASP) defined pain as a sensory and emotional experience associated with real or potential injuries, or described
More informationDoes repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache?
J Headache Pain (2004) 5:110 114 DOI 10.1007/s10194-004-0078-5 ORIGINAL Virginie Dousset Virginie Chrysostome Bruno Ruiz S. Irachabal Magalie Lafittau Françoise Radat Bruno Brochet Patrick Henry Does repeated
More informationVirtually everyone has experienced pain in one
Transfer of Advances in Sciences into Dental Education Recent Insights into Brainstem Mechanisms Underlying Craniofacial Pain Barry J. Sessle, B.D.S., M.D.S., B.Sc., Ph.D., F.R.S.C., D.Sc. (honorary) Abstract:
More informationAtenolol in the prophylaxis of chronic migraine: a 3-month open-label study
Edvardsson SpringerPlus 2013, 2:479 a SpringerOpen Journal RESEARCH Open Access Atenolol in the prophylaxis of chronic migraine: a 3-month open-label study Bengt Edvardsson Abstract Background: Chronic
More informationADVANCES IN MIGRAINE MANAGEMENT
ADVANCES IN MIGRAINE MANAGEMENT Joanna Girard Katzman, M.D.MSPH Assistant Professor, Dept. of Neurology Project ECHO, Chronic Pain Program University of New Mexico Outline Migraine throughout the decades
More informationV1-ophthalmic. V2-maxillary. V3-mandibular. motor
4. Trigeminal Nerve I. Objectives:. Understand the types of sensory information transmitted by the trigeminal system.. Describe the major peripheral divisions of the trigeminal nerve and how they innervate
More informationReceptors and Neurotransmitters: It Sounds Greek to Me. Agenda. What We Know About Pain 9/7/2012
Receptors and Neurotransmitters: It Sounds Greek to Me Cathy Carlson, PhD, RN Northern Illinois University Agenda We will be going through this lecture on basic pain physiology using analogies, mnemonics,
More informationBy the end of this lecture the students will be able to:
UNIT VII: PAIN Objectives: By the end of this lecture the students will be able to: Review the concept of somatosensory pathway. Describe the function of Nociceptors in response to pain information. Describe
More informationMigraine Migraine Age Specific Prevalence in the United States. Headache International Headache Society Classification
28 Primary Care Medicine Principles and Practice 29 October 28 Professor Peter J. Goadsby Peter.Goadsby@headache.ucsf.edu Department of Neurology Headache International Headache Society Classification
More informationPain. Types of Pain. Types of Pain 8/21/2013
Pain 1 Types of Pain Acute Pain Complex combination of sensory, perceptual, & emotional experiences as a result of a noxious stimulus Mediated by rapidly conducting nerve pathways & associated with increased
More informationCIC Edizioni Internazionali. Nociceptive blink reflex habituation biofeedback in migraine. Marina de Tommaso, PhD Marianna Delussi, PsyD
Nociceptive blink reflex habituation biofeedback in migraine Marina de Tommaso, PhD Marianna Delussi, PsyD Neurophysiopathology of Pain, Department of Basic Medical Sciences, Neuroscience and Sensory System
More informationWhat is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary
What is new in the migraine world! Modar Khalil Consultant neurologist Hull Royal Infirmary Overview Understanding the burden Commonly used terms Acute therapy What we currently have What we are going
More informationPreventive Effect of Greater Occipital Nerve Block on Severity and Frequency of Migraine Headache
Proceeding S.Z.P.G.M.I. Vol: 31(2): pp. 75-79, 2017. Preventive effect of Greater Occipital Nerve Block on Severity and Frequency of Migraine Headache Dr. Syed Mehmood Ali, Dr. Mudassar Aslam, Dr. Dawood
More informationNeurons of the Bed Nucleus of the Stria Terminalis (BNST)
Neurons of the Bed Nucleus of the Stria Terminalis (BNST) Electrophysiological Properties and Their Response to Serotonin DONALD G. RAINNIE a Harvard Medical School and Department of Psychiatry, Brockton
More informationPhoto-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers?
Schulte et al. The Journal of Headache and Pain (2015) 16:14 DOI 10.1186/s10194-015-0495-7 RESEARCH ARTICLE Open Access Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms
More informationSan Francisco Chronicle, June 2001
PAIN San Francisco Chronicle, June 2001 CONGENITAL INSENSITIVITY TO PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional)
More informationDisclosures. Triptans for Kids 5/16/13
5/16/13 Disclosures Triptans for Kids Amy A. Gelfand, MD GelfandA@neuropeds.ucsf.edu Departments of Neurology and Pediatrics UCSF Child Neurology and Headache Center I receive grant funding from: NIH/NINDS
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Frequency Domain Analysis of Heart Rate Variability in Tension Type Headache: A Case Control
More informationAn Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California
An Overview of MOH IHS ASIAN HA MASTERS SCHOOL MARCH 24, 2013 ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California President-Elect
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: March 16, 2018 Zomig Description Zomig / Zomig-ZMT
More informationPAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus. MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive
PAIN PAIN IS A SUBJECTIVE EXPERIENCE: It is not a stimulus MAJOR FEATURES OF THE PAIN EXPERIENCE: Sensory discriminative Affective (emotional) Cognitive MEASUREMENT OF PAIN: A BIG PROBLEM Worst pain ever
More informationSredišnja medicinska knjižnica
Središnja medicinska knjižnica Adamec I., Grahovac G., Krbot Skorić M., Chudy D., Hajnšek S, Habek M. (2014) Tongue somatosensory-evoked potentials in microvascular decompression treated trigeminal neuralgia.
More informationMedical Neuroscience Tutorial
Pain Pathways Medical Neuroscience Tutorial Pain Pathways MAP TO NEUROSCIENCE CORE CONCEPTS 1 NCC1. The brain is the body's most complex organ. NCC3. Genetically determined circuits are the foundation
More informationBasic Electrophysiology, the Electroretinogram (ERG) and the Electrooculogram (EOG) - Signal origins, recording methods and clinical applications
Basic Electrophysiology, the Electroretinogram (ERG) and the Electrooculogram (EOG) - Signal origins, recording methods and clinical applications The body is a complex machine consisting of the central
More informationSomatic Sensation (MCB160 Lecture by Mu-ming Poo, Friday March 9, 2007)
Somatic Sensation (MCB160 Lecture by Mu-ming Poo, Friday March 9, 2007) Introduction Adrian s work on sensory coding Spinal cord and dorsal root ganglia Four somatic sense modalities Touch Mechanoreceptors
More informationMedical Policy. Description/Scope. Position Statement. Rationale
Subject: Document#: Current Effective Date: 06/28/2017 Status: Reviewed Last Review Date: 05/04/2017 Description/Scope This document addresses occipital nerve stimulation (ONS), which involves delivering
More informationThe Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal
The Brainstem Migraine Generator - PET Studies in Migraine (1995) Migraine as a Channelopathy? Research From the Genetic Perspective (1996) Meningeal Sensitization, Central Sensitization, and Allodynia
More informationOccipital Nerve Stimulation with the Bion Microstimulator for the Treatment of Medically Refractory Chronic Cluster Headache
Pain Physician 2011; 14:435-440 ISSN 1533-3159 Case Report Occipital Nerve Stimulation with the Bion Microstimulator for the Treatment of Medically Refractory Chronic Cluster Headache Natalie H. Strand
More informationEFFECTS OF NITROUS OXIDE ON AUDITORY CORTICAL EVOKED POTENTIALS AND SUBJECTIVE THRESHOLDS
Br. J. Anaesth. (1988), 61, 606-610 EFFECTS OF NITROUS OXIDE ON AUDITORY CORTICAL EVOKED POTENTIALS AND SUBJECTIVE THRESHOLDS H. G. HOUSTON, R. J. McCLELLAND AND P. B. C. FENWICK General anaesthetics are
More informationSTRUCTURAL ORGANIZATION OF THE NERVOUS SYSTEM
STRUCTURAL ORGANIZATION OF THE NERVOUS SYSTEM STRUCTURAL ORGANIZATION OF THE BRAIN The central nervous system (CNS), consisting of the brain and spinal cord, receives input from sensory neurons and directs
More informationUCSF Neurology a welcoming place! Migraine Headache clinical classification. Secondary infection hemorrhage trauma tumour CSF pressure change
28 UCSF Neurology a welcoming place! Recent Advances in Neurology Ritz-Carlton Hotel, San Francisco 13 February 28 Professor Peter J. Goadsby Department of Neurology Headache clinical classification Age
More informationZomig. Zomig / Zomig-ZMT (zolmitriptan) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.22 Subject: Zomig Page: 1 of 5 Last Review Date: November 30, 2018 Zomig Description Zomig / Zomig-ZMT
More informationChronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary
Chronic Migraine in Primary Care December 11 th, 2017 Werner J. Becker University of Calgary Disclosures Faculty: Werner J. Becker Relationships with commercial interests: Grants/Research Support: Clinical
More informationCluster headache and paroxysmal hemicrania: differential diagnosis
Blackwell Science, LtdOxford, UKCHACephalalgia0333-1024Blackwell Science, 2004254244248Original ArticleCH and PH: differential diagnosisj Zidverc-Trajkovic et al. Cluster headache and paroxysmal hemicrania:
More informationOveruse of barbiturate and opioid containing medications for primary headache disorders Description
Measure Title Overuse of barbiturate and opioid containing medications for primary headache disorders Description Percentage of s age 12 years and older with a diagnosis of primary headache who were prescribed
More informationONZETRA XSAIL (sumatriptan) nasal powder
ONZETRA XSAIL (sumatriptan) nasal powder Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationTears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE
Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE IHS Classification 1989 (updated 2004) Primary Headaches 4 categories Migraine Tension-type Cluster and other trigeminal
More informationSensory coding and somatosensory system
Sensory coding and somatosensory system Sensation and perception Perception is the internal construction of sensation. Perception depends on the individual experience. Three common steps in all senses
More informationMigraine Pathophysiology. Robert E. Shapiro, MD, PhD
Migraine Pathophysiology Robert E. Shapiro, MD, PhD Disclosures Eli Lilly Member, Clinical Trials Data Monitoring Committee Learning Objectives By the end of this course participants will be able to describe:
More informationSeeking the best care for acute migraine
J Headache Pain (2002) 3:1 5 Springer-Verlag 2002 EDITORIAL Marcello Fanciullacci Seeking the best care for acute migraine M. Fanciullacci ( ) Headache Center, Department of Internal Medicine, University
More informationThe main features of the TACs:
Pathophysiology of trigeminal autonomic cephalalgias Jasna Zidverc Trajković Headache center The main features of the TACs: 1. Trigeminal distribution of the pain 2. Ipsilateral cranial autonomic features
More informationSpinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018
Spinal Cord Injury Pain Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018 Objectives At the conclusion of this session, participants should be able to: 1. Understand the difference between nociceptive
More informationPathophysiology of Migraine
Pathophysiology of Migraine 1 MIGRAINE PATHOPHYSIOLOGY: A NEUROVASCULAR HEADACHE Objectives Review the neurobiology of migraine - Features of acute attack - neuroanatomical substrates Discuss the current
More informationPeripheral nerve stimulation suppression of C-fiber-evoked flexion reflex in rats. Part 1: Parameters of continuous stimulation
J Neurosurg 63:612-616, 1985 Peripheral nerve stimulation suppression of C-fiber-evoked flexion reflex in rats Part 1: Parameters of continuous stimulation BENGT H. SJOLUND, M.D., PH.D. Science Branch,
More informationCHAPTER 10 THE SOMATOSENSORY SYSTEM
CHAPTER 10 THE SOMATOSENSORY SYSTEM 10.1. SOMATOSENSORY MODALITIES "Somatosensory" is really a catch-all term to designate senses other than vision, hearing, balance, taste and smell. Receptors that could
More informationCGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS)
CGRP, MONOCLONAL ANTIBODIES AND SMALL MOLECULES (-GEPANTS) Hans-Christoph Diener Senior Professor of Clinical Neurosciences University Duisburg-Essen Germany CGRP, Monoclonal Antibodies and Small Molecules
More informationPharmacology of Pain Transmission and Modulation
Pharmacology of Pain Transmission and Modulation 2 Jürg Schliessbach and Konrad Maurer Nociceptive Nerve Fibers Pain is transmitted to the central nervous system via thinly myelinated Aδ and unmyelinated
More informationReasons for thinking so, according to von Frey:
Reasons for thinking so, according to von Frey: The experiment consisted of sticking a pig bristle against the eye. Even with fairly light contact, the bristle was painful...... and a warm and cold bristle
More informationSomatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks
Brain Advance Access published November 24, 2004 doi:10.1093/brain/awh334 Brain Page 1 of 6 Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine
More informationUsing Transcranial magnetic stimulation to improve our understanding of Transverse Myelitis
Using Transcranial magnetic stimulation to improve our understanding of Transverse Myelitis Kathy Zackowski, PhD, OTR Kennedy Krieger Institute Johns Hopkins University School of Medicine TMS (transcranial
More informationDISCLOSURES FUNCTIONS OF THE HYPOTHALAMUS
NOVEL THERAPEUTIC TARGETS: THE HYPOTHALAMUS Andrew Charles, M.D. Professor Director, UCLA Goldberg Migraine Program Meyer and Renee Luskin Chair in Migraine and Headache Studies David Geffen School of
More informationEntrainment of neuronal oscillations as a mechanism of attentional selection: intracranial human recordings
Entrainment of neuronal oscillations as a mechanism of attentional selection: intracranial human recordings J. Besle, P. Lakatos, C.A. Schevon, R.R. Goodman, G.M. McKhann, A. Mehta, R.G. Emerson, C.E.
More informationWhat cranial nerves can we monitor?
What cranial nerves can we monitor? Laura Hemmer, M.D. SNACC Neuromonitoring Subcommittee Linda Aglio, M.D., M.S. Laura Hemmer, M.D. Antoun Koht, M.D. David L. Schreibman, M.D. What cranial nerve (CN)
More informationSurface recording of muscle activity
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Hands-on Course 5 Electromyography: Surface, needle conventional and single fiber - Level 1-2 Surface recording
More informationNMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance
Vol. 19 No. 1(Suppl.) January 2000 Journal of Pain and Symptom Management S7 Proceedings Supplement NDMA-Receptor Antagonists: Evolving Role in Analgesia NMDA-Receptor Antagonists and Opioid Receptor Interactions
More informationPAIN MODULATION. numerical value. adjectives. DR SYED SHAHID HABIB Professor & Consultant Dept. of Physiology College of Medicine & KKUH
PAIN MODULATION numerical value adjectives DR SYED SHAHID HABIB Professor & Consultant Dept. of Physiology College of Medicine & KKUH OBJECTIVES At the end of this lecture you should be able to describe:
More informationINTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING FOR MICROVASCULAR DECOMPRESSION SURGERY IN PATIENTS WITH HEMIFACIAL SPASM
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING FOR MICROVASCULAR DECOMPRESSION SURGERY IN PATIENTS WITH HEMIFACIAL SPASM WILLIAM D. MUSTAIN, PH.D., CNIM, BCS-IOM DEPARTMENT OF OTOLARYNGOLOGY AND COMMUNICATIVE
More informationSomatic Sensory System I. Background
Somatic Sensory System I. Background A. Differences between somatic senses and other senses 1. Receptors are distributed throughout the body as opposed to being concentrated at small, specialized locations
More informationPreventive Effect of Greater Occipital Nerve Block on Severity and Frequency of Migraine Headache
Global Journal of Health Science; Vol. 6, No. 6; 2014 ISSN 1916-9736 E-ISSN 1916-9744 Published by Canadian Center of Science and Education Preventive Effect of Greater Occipital Nerve Block on Severity
More informationPhenotype of patients responsive to occipital nerve stimulation for refractory head pain
Phenotype of patients responsive to occipital nerve stimulation for refractory head pain Koen Paemeleire 1*, MD, PhD, Jean-Pierre Van Buyten 2*, MD, Machteld Van Buynder 2, Dario Alicino 2, MD, Georges
More informationIs the Migraid device an asset in the non-pharmacologic treatment of migraine?
Acta neurol. belg., 2007, 107, 40-46 Is the Migraid device an asset in the non-pharmacologic treatment of migraine? Herman PIETERSE 1,3, Joop A. M. KUSTER 2 and Luc M. VAN BORTEL 1 1 Heymans Institute
More information*Anteriolateral spinothalamic tract (STT) : a sensory pathway that is positioned anteriorly and laterally in the spinal cord.
*somatic sensations : PAIN *Anteriolateral spinothalamic tract (STT) : a sensory pathway that is positioned anteriorly and laterally in the spinal cord. *This pathway carries a variety of sensory modalities:
More informationSpecial Issue on Pain and Itch
Special Issue on Pain and Itch Title: Recent Progress in Understanding the Mechanisms of Pain and Itch Guest Editor of the Special Issue: Ru-Rong Ji, PhD Chronic pain is a major health problem world-wide.
More informationClarke's Column Neurons as the Focus of a Corticospinal Corollary Circuit. Supplementary Information. Adam W. Hantman and Thomas M.
Clarke's Column Neurons as the Focus of a Corticospinal Corollary Circuit Supplementary Information Adam W. Hantman and Thomas M. Jessell Supplementary Results Characterizing the origin of primary
More informationChapter 16. Sense of Pain
Chapter 16 Sense of Pain Pain Discomfort caused by tissue injury or noxious stimulation, and typically leading to evasive action important /// helps to protect us lost of pain in diabetes mellitus = diabetic
More information